The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Search

      
          View 
        
      Event
    
      2023 CPhI Worldwide
    
        Date:
        
            2023/10/24
                        to 2023/10/26
                      
        Location:
        Barcelona, Spain
      
          View 
        
      Event
    
      2023 CPhI North America
    
        Date:
        
            2023/04/25
                        to 2023/04/27
                      
        Location:
        Philadelphia, USA
      
          View 
        
      Event
    
      2022 CPhI Worldwide
    
        Date:
        
            2022/11/01
                        to 2022/11/03
                      
        Location:
        Frankfurt, Germany
      
          View 
        
      Event
    
      2021 CPhI Worldwide
    
        Date:
        
            2021/11/09
                        to 2021/11/11
                      
        Location:
        Milan, Italy
      
      View

Article / Jun 30, 2023
Excellence in pharmaceuticalsUSA Today, 30 June 2023

      View

Press Release / Mar 17, 2021
Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmicShowing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction

      View

News / Jul 23, 2021
Hovione signs the COP26 manifest to stop climate changesBCSD Portugal, 23 July 2021

      View

Press Clipping / May 12, 2025
Partnership advances liver cancer treatmentScientist Live, 12 May 2025

      View

Press Clipping / Nov 12, 2018
How Hovione grew from a basement lab to a global pharmaceutical services companyC&EN, November 12, 2018

      View

Press Clipping / Apr 06, 2023
Hovione 2023 CDMO Leadership Awards Winner InterviewOutsourced Pharma, April 2023

Browser not supported

Search

Types

Press Room

Categories

2023 CPhI Worldwide

2023 CPhI North America

2022 CPhI Worldwide

2021 CPhI Worldwide

Excellence in pharmaceuticals

Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic

Hovione signs the COP26 manifest to stop climate changes

Partnership advances liver cancer treatment

How Hovione grew from a basement lab to a global pharmaceutical services company

Hovione 2023 CDMO Leadership Awards Winner Interview